WHO ICTRP trial
Prospective Study on a Plasma Metabolome Multimarker Panel MxP® PancreasScore…
DRKS00010866 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00010866 |
|---|---|
| Public title | Prospective Study on a Plasma Metabolome Multimarker Panel MxP® PancreasScore for the Diagnosis of Pancreatic Cancer in Cohorts at Risk |
| Scientific title | Prospective Study on a Plasma Metabolome Multimarker Panel MxP® PancreasScore for the Diagnosis of Pancreatic Cancer in Cohorts at Risk - META-PAC |
| Primary sponsor | LMU Klinikum |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | PANKREASRAUMFORDERUNG E10-E14 C25;Diabetes mellitus;Malignant neoplasm of pancreas;E10-E14 |
| Interventions | Group 1: In this study, a blood test for exclusion of pancreatic cancer will be developed in high-risk groups. This risk group includes people with a chronic inflammation of the pancreas, newly diagnosed diabetes or a genetic predisposition… |
| Registration date | Jul 28, 2016 |
| Target size | 1625 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: